logo

For the Inventor, By the Inventor

Toulouse, France

Armand Amselem

This inventor holds 10 USPTO granted patents. Top assignees: Parcor, Centre D'etudes Pour L'industrie Pharmaceutique, Sanofi. Active years: 1976-1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Armand Amselem. Retrieved from https://idiyas.com/inventor/armand-amselem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 1.2

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:

goldMedal5 out of 25 
 
Parcor
 patents
silverMedal3 out of 7 
 
Centre D'etudes Pour L'industrie Pharmaceutique
 patents
bronzeMedal1 out of 1,547 
 
Sanofi
 patents
4. 1 out of 44 
 
Sanofi Sa
 patents

Years Active: 1976-1983

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4400384 - 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-c] pyridine (1983-08-23),
2. 4321266 - 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine (1982-03-23),
3. 4097482 - 5-O-Cyanobenzyl-4,5,6,7-tetrahydro-thieno�3,2-c!pyridine maleate (1978-06-27),
4. 4080447 - Therapeutic composition having an inhibiting activity on blood plate (1978-03-21),
5. 4018786 - 2-Aminothiazolines and a process for preparation thereof (1977-04-19),
6. 3995050 - Amino-2 imidazoles (1976-11-30),
7. 3983125 - Thieno-pyridine derivatives, process for their preparation and their (1976-09-28),
8. 3969358 - Process for the preparation of thieno [3,2-c] pyridine and thieno [2,3-c] p (1976-07-13),
9. 3957995 - Pharmaceutical composition comprising vincamine and theophylline (1976-05-18),
10. 3957981 - Pharmaceutical composition comprising vincamine and acetylsalicyclic acid (1976-05-18),

Title: Armand Amselem: A Pioneer in Pharmaceutical Innovation

Introduction

Armand Amselem is a notable inventor based in Toulouse, France, recognized for his significant contributions to the pharmaceutical industry. With a total of 10 patents to his name, Amselem's work focuses on innovative compounds that have therapeutic applications, particularly related to blood platelet aggregation.

Latest Patents

Among his latest patents, Amselem has developed novel compounds, including the 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-c] pyridine acid addition salts. This invention highlights its inhibitory action against blood platelet aggregation without eliciting anti-inflammatory effects. In addition, he has also patented the free base form of this compound, which involves methods of preparation and therapeutic uses aimed at preventing blood platelet aggregation in warm-blooded animals.

Career Highlights

Amselem has built a notable career, having worked with prestigious companies such as Parcor and Centre d'Études Pour L'Industrie Pharmaceutique. His work at these organizations has facilitated significant advancements in pharmaceutical research, allowing him to explore and develop new therapeutic agents.

Collaborations

Throughout his career, Armand Amselem has collaborated with esteemed colleagues, including Fernand Eloy and Jean-Pierre Maffrand. These partnerships have contributed to his innovative research and the successful development of his patented inventions.

Conclusion

Armand Amselem’s contributions to the pharmaceutical industry through his innovative patents underscore his role as a key figure in pharmaceutical research. His work not only advances scientific understanding but also holds promise for future therapeutic applications, benefiting both the medical community and patients globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…